Intelligent bio solutions inc. reports fiscal 2024 fourth quarter and full year financial results and operational highlights

- fourth-quarter revenue of $0.73 million, up 64% year-over-year – - full-year revenue of $3.11 million, up 148% year-over-year – - as of june 30, 2024, the company had $6.30 million in cash - new york, sept. 19, 2024 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“inbs” or the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, announced its financial results for the fiscal fourth quarter and full-year ended june 30, 2024, and provided a business update.
INBS Ratings Summary
INBS Quant Ranking